Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh
· Delayed Price · Currency is BDT 13.40
+0.20 (1.52%)
At close: Jun 4, 2025
Advent Pharma Revenue
Advent Pharma had revenue of 127.46M BDT in the quarter ending March 31, 2025, a decrease of -17.42%. This brings the company's revenue in the last twelve months to 478.96M, down -15.79% year-over-year. In the fiscal year ending June 30, 2024, Advent Pharma had annual revenue of 571.67M with 2.44% growth.
Revenue (ttm)
478.96M
Revenue Growth
-15.79%
P/S Ratio
2.59
Revenue / Employee
1.54M
Employees
312
Market Cap
1.24B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grameenphone | 157.46B |
| Square Pharmaceuticals PLC. | 75.86B |
| British American Tobacco Bangladesh Company | 98.15B |
| Robi Axiata PLC. | 97.75B |
| Walton Hi-Tech Industries | 78.24B |
| BRAC Bank PLC. | 65.27B |
| Bangladesh Export Import Company | 17.72B |
| Berger Paints Bangladesh | 27.70B |